Lung Cancer Trial, Not Yet Recruiting NCT06829641 Sponsor: West China Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT06829641
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People diagnosed with stage IIIB or IIIC non-small cell lung cancer (a specific type and stage of lung cancer), confirmed by laboratory testing of tissue or cell samples using a recognised staging system.
  • People whose cancer has tested negative for certain specific genetic changes (known as EGFR-sensitive mutations or ALK/ROS1 fusions) that can affect how the cancer behaves.
  • People who have not previously received chemotherapy, radiation therapy, surgery, or immunotherapy for their cancer.
  • People who have a general health and activity level score between 0 and 2 on a standard medical scale (where 0 means fully active and 2 means capable of self-care but unable to carry out physically demanding activities).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had another type of cancer in the past that required treatment, or people for whom key information about their diagnosis and treatment history (such as cancer stage, cancer type, details of prior treatments, and scan results) is missing or incomplete.
  • People who are currently taking part in another clinical trial involving an anti-cancer drug where the treatment being given is not known.
  • People who have previously had surgery, radiation therapy, or any other systemic (whole-body) treatment for their non-small cell lung cancer, including procedures such as radiofrequency ablation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
West China Hospital
Registry
ClinicalTrials.gov
Start date
9 August 2025
Est. completion
1 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

major pathological response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov